
E241: Beyond the Survey: How Generative AI Captures the Patient Voice at Scale — and Why It's Pharma's Next Growth Lever
AI For Pharma Growth
How AI Captures Open-Ended Patient Conversations
Mattia explains how conversational AI motivates patients to share detailed experiences while transforming free-form stories into structured data.
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Mattia Marco Caruson, co-founder and CEO of mama health, about how generative AI is changing the way pharma understands the patient journey.
Mattia explains why traditional methods such as surveys, focus groups and clinician interviews often capture only fragments of what patients actually experience. In rare and chronic diseases, the most important parts of the journey can happen between appointments, long before a patient reaches the right doctor or treatment.
The conversation explores how generative AI can enable open-ended conversations with patients at scale and then turn those qualitative stories into structured, analysable data. Instead of forcing people to reduce years of lived experience to a multiple-choice answer, AI can help capture their own words, frustrations, unmet needs and decision points.
Mattia also discusses how these insights can influence launch strategy, positioning, patient support, medical affairs and market access. He argues that pharma should stop viewing AI only as a way to make existing processes faster and start asking what entirely new capabilities it unlocks.
They also examine consent, privacy, hallucination risk and the need to ground patient-facing AI in trusted medical sources.
Topics Covered
Why surveys miss important parts of the patient journey
AI-powered patient conversations at scale
Turning qualitative stories into structured insight
Understanding unmet needs and treatment decisions
Patient insight for launch and commercial strategy
Consent, privacy and data governance
Grounding AI in trusted medical knowledge
Why pharma needs to listen directly to patients
About Eularis
Eularis builds AI capability inside pharma and biotech — over 20 years applying AI to real pharmaceutical problems, inside real pharmaceutical and biotech companies.
Keynotes and live sessions — Working sessions for pharma teams where nobody leaves with notes. They leave with working prompts and real capability they've already run on their own work.
The AI Enablement Institute — Strategy and a workshop get you started; neither stays current. Most pharma companies already have a generic AI course library. None of it is written for a regulatory writer, an MSL or a market access lead trying to get today's work done. Training is an event; enablement is capability that stays current. The Institute runs shared foundations for the regulated constraints, then tracks by business unit function, with new content monthly, live office hours with Dr Andree Bates, and per-person records a sponsor can show an auditor. One price per business unit, no per-seat charges.
AI Strategic Blueprint and Governance — Board-ready strategy that links initiatives to commercial outcomes, with the sequencing, governance, capability and financial logic to survive scrutiny.
AI Custom Builds for BioPharma — Design and build of the AI solutions that make strategic sense in your operating reality, tied back to the Blueprint.
Start with the Institute → https://eularis.com/institute/
Everything else → https://eularis.com
About the Podcast
AI For Pharma Growth is the podcast from Dr Andree Bates, helping pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands and improve company results. The show demystifies AI for biopharma leaders, from start-up biotech through to Big Pharma.
Dr. Andree Bates LinkedIn | Facebook | X


